It is also worth noting that, unlike most tumors, CD38 has been detected to be down-regulated in PCa, especially in advanced castration-resistant prostate cancer (CRPC), which may be due to methylation silencing (38, 39). This evidence concerns the gene CD38 and posterior cortical atrophy.